Literature DB >> 20447150

A marker associated with increased risk for severe liver disease in cystic fibrosis.

W de Haan1.   

Abstract

Genetic modifiers of liver disease in cystic fibrosis Bartlett et al. (2009) The Journal of the American Medical Association 302: 1076-1083.

Entities:  

Year:  2010        PMID： 20447150     DOI： 10.1111/j.1399-0004.2009.01365_1.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


  3 in total

Review 1.  Aetiopathogenesis of liver changes in the course of cystic fibrosis, considering disturbances of the bile acid profile as well as genetic and immunological factors.

Authors:  Sabina Więcek; Halina Woś; Urszula Grzybowska-Chlebowczyk
Journal:  Prz Gastroenterol       Date:  2013-10-28

2.  Assessment of Liver Fibrosis with the Use of Elastography in Paediatric Patients with Diagnosed Cystic Fibrosis.

Authors:  Sabina Wiecek; Piotr Fabrowicz; Halina Wos; Bożena Kordys-Darmolinska; Maciej Cebula; Katarzyna Gruszczynska; Urszula Grzybowska-Chlebowczyk
Journal:  Dis Markers       Date:  2022-03-19       Impact factor: 3.434

3.  Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.

Authors:  Sabina Więcek; Halina Woś; Andrzej Pogorzelski; Bożena Kordys-Darmolinska; Henryk Mazurek; Urszula Grzybowska-Chlebowczyk
Journal:  Mediators Inflamm       Date:  2020-03-25       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.